Cognitive treatments in schizophrenia.
Phase of Trial: Phase IV
Latest Information Update: 21 Jun 2012
At a glance
- Drugs Atomoxetine (Primary)
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 21 Jun 2012 Actual patient number is 119 according to ClinicalTrials.gov.
- 24 May 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.
- 24 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.